Ann-Margret Ervin, PhD, MPH

Dr. Ann-Margret Ervin is an Associate Scientist at Johns Hopkins University, with a focus on the design and conduct of randomized clinical trials, particularly in the field of ocular disease and visual impairment. Her research encompasses a wide range of topics, including age-related macular degeneration, cataracts, and diabetic retinopathy. Dr. Ervin serves as Co-Principal Investigator for several significant projects, including a multicenter observational study of Stargardt Disease and a clinical trial investigating the effects of lutein and zeaxanthin on ocular health. Additionally, she is engaged in research examining the ethical implications of federal regulations on institutional review boards (IRBs) and their impact on multicenter clinical trials.In her role at Johns Hopkins, Dr. Ervin also teaches courses on clinical trials management and quality assurance, contributing to the education of future public health professionals. Her extensive experience in clinical trial methodology and her commitment to improving research ethics make her a valuable asset to the field of epidemiology and public health.